Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0U6OY
|
|||
Drug Name |
Piperazinyl norbenzomorphane compound 2
|
|||
Synonyms |
PMID30185082-Compound-33
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H33N3O2
|
|||
Canonical SMILES |
CCCN1CCN(CC1)C2=CC3=C(C=C2)C4CCN(C3C4)C(=O)OCC5=CC=CC=C5
|
|||
InChI |
1S/C26H33N3O2/c1-2-11-27-13-15-28(16-14-27)22-8-9-23-21-10-12-29(25(17-21)24(23)18-22)26(30)31-19-20-6-4-3-5-7-20/h3-9,18,21,25H,2,10-17,19H2,1H3
|
|||
InChIKey |
FFCRKESJGXTNRJ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] |
Target's Patent Info | Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | The sigma-2 (-2) receptor: a review of recent patent applications: 2013-2018.Expert Opin Ther Pat. 2018 Sep;28(9):655-663. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.